
MAKMIROR 200 mg coated tablets contain the active substance nifuratel. MAKMIROR is indicated for the treatment of vulvovaginal infections and vaginal discharge caused by pathogenic microorganisms: Trichomonas, Monilia, micelles. Urinary tract infections.
Do not take MAKMIROR
If you are hypersensitive to the active substance - nifuratel or any of the other ingredients of MAKMIROR.
Take special care with MAKMIROR
During treatment to avoid intercourse.
With glucose-6-phosphate dehydrogenase deficiency may experience hemolytic anemia.
Taking MAKMIROR food and drink
During treatment should avoid alcohol, which can cause discomfort and nausea resolved spontaneously.
Pregnancy and lactation
During pregnancy or in early childhood product can be used only in case of absolute necessity under medical supervision.
Vaginal infections
Adults: Take 1 tablet 3 times daily after meals for one week, for both partners.
Patients treated with oral administration should take four or more tablets daily.
Urinary tract infections
Adults: 3 to 6 tablets daily for 1-2 weeks, depending on the cause and severity of the infection.
By the gastrointestinal tract is sometimes observed stomach upset (nausea, etc..), Peripheral neuropathy, allergic reactions, hepatotoxicity and others.
Do not store above 25 ° C.
Keep out of reach of children. MAKMIROR Do not use after the expiry date stated on the pack.
What MAKMIROR
1 tablet contains:
Active substance: 200 mg Nifuratel
Other ingredients: starch, talc, magnesium stearate, magnesium carbonate, gelatin, sucrose, polyethylene glycol 6000, titanium dioxide, acacia gum, wax.
MAKMIROR looks like and contents of pack
MAKMIROR coated tablets are available in blister packs containing 20 tablets in a carton, together with a package leaflet.